TMTA.L Share Price (TMTA)

At least you have a share with cash assets greater than its share price here.

Adastra - but what if the delays (plural) aren't down to that?

And what if the acquisition ultimately doesn't go ahead?

Logic says to invest in TMTA with minute overheads and 17.15p a share cash on deposit assets as opposed to Belluscura needing cash to meet demand.

The offer of 3 Belluscura shares for 4 TMTA initially valued TMTA at 21p share which was a decent risk premium. The fall in BELL to 22p means that each TMTA is only being valued at 16.5p which is laughably less than its NAV.

I'm pretty sure that the offer doc delay is due to TMTA doing its due diligence and wanting to see concrete evidence of progress and sales. Once that has been established then the transaction should quickly follow.

All the exposure to the huge potential upside of Belluscura with covered risk due diligence done by directors here plus NAV of 17.25p a share cash on deposit.

Just waiting on the OK 3 Belluscura shares for every 4 TMTA shares to be approved as a cost-effective risk-managed way of getting exposure to Bells oxygen concentrator roll out. The RNS regarding Chinese certification for use could transform Belluscura as it targets far east.